SO
ARRY

STRS Ohio’s Array Biopharma Inc ARRY Stock Holding History

STRS Ohio’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-70,700
Closed -$3.27M – 2218
2019
Q2 		$3.27M Buy
70,700
+1,400
+2% +$39.3K 0.01% 545
2019
Q1 		$1.69M Buy
69,300
+15,900
+30% +$331K 0.01% 681
2018
Q4 		$760K Sell
53,400
-4,700
-8% -$71.3K ﹤0.01% 916
2018
Q3 		$883K Sell
58,100
-6,200
-10% -$95K ﹤0.01% 954
2018
Q2 		$1.08M Buy
64,300
+43,200
+205% +$687K ﹤0.01% 857
2018
Q1 		$344K Buy
21,100
+19,000
+905% +$304K ﹤0.01% 1410
2017
Q4 		$26K Buy
2,100
+2,000
+2,000% +$22.7K ﹤0.01% 1805
2017
Q3 		$1K Sell
100
-7,700
-99% -$71.5K ﹤0.01% 1913
2017
Q2 		$65K Buy
+7,800
New +$63.8K ﹤0.01% 1739
2015
Q4 		– Sell
-157,200
Closed -$716K – 1985
2015
Q3 		$716K Buy
+157,200
New +$932K ﹤0.01% 1025

Other funds holding ARRY

ASN
Advisory Services Network Atlanta, Georgia $7.52B AUM 29.01% 1-Year Est. Return

STRS Ohio's ARRY Position: Q3 2019 in Review

STRS Ohio sold out of Array Biopharma Inc (ARRY) in Q3 2019, closing a stake of 70,700 shares — an estimated $3.27M sold.

STRS Ohio first reported a position in ARRY in Q3 2015 and held it in 10 quarters. The position peaked at $3.27M in Q2 2019. 1 fund tracked by Wall St. Rank holds ARRY as of Q3 2019.

  • STRS Ohio reported no remaining Array Biopharma Inc position as of Q3 2019 after selling out during the quarter.
  • STRS Ohio sold 70,700 Array Biopharma Inc shares in Q3 2019, an estimated $3.27M.
  • STRS Ohio first reported a position in Array Biopharma Inc in Q3 2015 and held it in 10 quarters.
  • STRS Ohio's Array Biopharma Inc position peaked at $3.27M in Q2 2019.
  • 1 fund tracked by Wall St. Rank held Array Biopharma Inc as of Q3 2019.

Based on STRS Ohio's 13F filing for Q3 2019, filed 21 Oct 2019.